{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:51:38Z","timestamp":1771919498984,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971645"],"award-info":[{"award-number":["81971645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s12149-021-01640-5","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T12:04:00Z","timestamp":1623153840000},"page":"1048-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Usefulness of 18F-FDG PET\/CT in treatment-naive patients with thymic squamous cell carcinoma"],"prefix":"10.1007","volume":"35","author":[{"given":"Yuan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-132X","authenticated-orcid":false,"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"1640_CR1","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1634\/theoncologist.11-8-887","volume":"11","author":"RF Riedel","year":"2006","unstructured":"Riedel RF, Burfeind WRJ. Thymoma: benign appearance, malignant potential. Oncologist. 2006;11:887\u201394.","journal-title":"Oncologist"},{"key":"1640_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.athoracsur.2013.04.078","volume":"96","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhao H, Hu D, Fan L, Shi J, Fang W. Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases. Ann Thorac Surg. 2013;96:1019\u201324.","journal-title":"Ann Thorac Surg"},{"key":"1640_CR3","first-page":"541","volume":"9","author":"E Ruffini","year":"2014","unstructured":"Ruffini E, Detterbeck F, Van Raemdonck D, Rocco G, Thomas P, Weder W, et al. Thymic carcinoma: a cohort study of patients from the European society of thoracic surgeons database. Lung Cancer. 2014;9:541\u20138.","journal-title":"Lung Cancer"},{"key":"1640_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","volume":"149","author":"U Ahmad","year":"2015","unstructured":"Ahmad U, Yao X, Detterbeck F, Huang J, Antonicelli A, Filosso PL, et al. Thymic carcinoma outcomes and prognosis: results of an international analysis. J Thorac Cardiovasc Surg. 2015;149:95\u2013101.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1640_CR5","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","volume":"29","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Petrini I, Rajan A, Wang Y, Giaccone G. Thymic malignancies: from clinical management to targeted therapies. J Clin Oncol. 2011;29:4820\u20137.","journal-title":"J Clin Oncol"},{"key":"1640_CR6","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3389\/fonc.2020.01478","volume":"10","author":"A Cafaro","year":"2020","unstructured":"Cafaro A, Bongiovanni A, Di Iorio V, Oboldi D, Masini C, Ibrahim T. Pembrolizumab in a patient with heavily pre-treated squamous cell thymic carcinoma and cardiac impairment: a case report and literature review. Front Oncol. 2020;10:1478.","journal-title":"Front Oncol"},{"key":"1640_CR7","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2147\/CMAR.S155542","volume":"10","author":"B Yu","year":"2018","unstructured":"Yu B, Zhu X, Liang Z, Sun Y, Zhao W, Chen K. Clinical usefulness of (18)F-FDG PET\/CT for the detection of distant metastases in patients with non-small cell lung cancer at initial staging: a meta-analysis. Cancer Manag Res. 2018;10:1859\u201364.","journal-title":"Cancer Manag Res"},{"key":"1640_CR8","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1148\/rg.2018180060","volume":"38","author":"A Kandathil","year":"2018","unstructured":"Kandathil A, Kay FU, Butt YM, Wachsmann JW, Subramaniam RM. Role of FDG PET\/CT in the eighth edition of TNM staging of non-small cell lung cancer. Radiographics. 2018;38:2134\u201349.","journal-title":"Radiographics"},{"key":"1640_CR9","first-page":"20","volume":"39","author":"G Kanyilmaz","year":"2020","unstructured":"Kanyilmaz G, Benli Yavuz B, Aktan M, Sahin O. Prognostic importance of (18)F-fluorodeoxyglucose uptake by positron emission tomography for stage III non-small cell lung cancer treated with definitive chemoradiotherapy. Rev Esp Med Nucl Imagen Mol. 2020;39:20\u20136.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"1640_CR10","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.2967\/jnumed.108.054098","volume":"50","author":"H Jadvar","year":"2009","unstructured":"Jadvar H, Alavi A, Gambhir SS. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med. 2009;50:1820\u20137.","journal-title":"J Nucl Med"},{"key":"1640_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00259-017-3885-z","volume":"45","author":"Z Lv","year":"2018","unstructured":"Lv Z, Fan J, Xu J, Wu F, Huang Q, Guo M, et al. Value of (18)F-FDG PET\/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients. Eur J Nucl Med Mol Imaging. 2018;45:735\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1640_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13550-020-00639-9","volume":"10","author":"X Wu","year":"2020","unstructured":"Wu X, Huang Y, Zhao Q, Wang L, Song X, Li Y, et al. PD-L1 expression correlation with metabolic parameters of FDG PET\/CT and clinicopathological characteristics in non-small cell lung cancer. EJNMMI Res. 2020;10:51.","journal-title":"EJNMMI Res"},{"key":"1640_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12149-019-01374-5","volume":"33","author":"X Wu","year":"2019","unstructured":"Wu X, Huang Y, Li Y, Wang Q, Wang H, Jiang L. (18)F-FDG PET\/CT imaging in pulmonary sarcomatoid carcinoma and correlation with clinical and genetic findings. Ann Nucl Med. 2019;33:647\u201356.","journal-title":"Ann Nucl Med"},{"key":"1640_CR14","doi-asserted-by":"publisher","first-page":"20180598","DOI":"10.1259\/bjr.20180598","volume":"92","author":"Y Xie","year":"2019","unstructured":"Xie Y, Zhang S, Liu J, Liang X, Zhang X, Zhang Y, et al. Value of CT spectral imaging in the differential diagnosis of thymoma and mediastinal lymphoma. Br J Radiol. 2019;92:20180598.","journal-title":"Br J Radiol"},{"key":"1640_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.lungcan.2013.09.013","volume":"83","author":"PL Filosso","year":"2014","unstructured":"Filosso PL, Ruffini E, Lausi PO, Lucchi M, Oliaro A, Detterbeck F. Historical perspectives: The evolution of the thymic epithelial tumors staging system. Lung Cancer. 2014;83:126\u201332.","journal-title":"Lung Cancer"},{"key":"1640_CR16","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","volume":"48","author":"A Masaoka","year":"1981","unstructured":"Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48:2485\u201392.","journal-title":"Cancer"},{"key":"1640_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","volume":"44","author":"K Koga","year":"1994","unstructured":"Koga K, Matsuno Y, Noguchi M, Mukai K, Asamura H, Goya T, et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int. 1994;44:359\u201367.","journal-title":"Pathol Int"},{"key":"1640_CR18","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","volume":"9","author":"FC Detterbeck","year":"2014","unstructured":"Detterbeck FC, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, et al. The IASLC\/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol. 2014;9:S65-72.","journal-title":"J Thorac Oncol"},{"key":"1640_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.lungcan.2013.08.003","volume":"82","author":"F Lococo","year":"2013","unstructured":"Lococo F, Cesario A, Okami J, Cardillo G, Cavuto S, Tokunaga T, et al. Role of combined 18F-FDG-PET\/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis. Lung Cancer. 2013;82:245\u201351.","journal-title":"Lung Cancer"},{"key":"1640_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s11748-020-01439-7","volume":"69","author":"T Ito","year":"2021","unstructured":"Ito T, Suzuki H, Sakairi Y, Wada H, Nakajima T, Yoshino I. 18F-FDG-PET\/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors. Gen Thorac Cardiovasc Surg. 2021;69:274\u201381.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"1640_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.33160\/yam.2019.03.020","volume":"62","author":"M Ishibashi","year":"2019","unstructured":"Ishibashi M, Tanabe Y, Yunaga H, Miyoshi H, Miwa K, Nakamura H, et al. Usefulness of preoperative (18)F-FDG PET\/CT for patients with thymic epithelial tumors. Yonago Acta Med. 2019;62:146\u201352.","journal-title":"Yonago Acta Med"},{"key":"1640_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/RLU.0000000000001032","volume":"41","author":"SY Park","year":"2016","unstructured":"Park SY, Cho A, Bae MK, Lee CY, Kim DJ, Chung KY. Value of 18F-FDG PET\/CT for predicting the world health organization malignant grade of thymic epithelial tumors: focused in volume-dependent parameters. Clin Nucl Med. 2016;41:15\u201320.","journal-title":"Clin Nucl Med"},{"key":"1640_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5761\/atcs.oa.17-00108","volume":"24","author":"E Kaba","year":"2018","unstructured":"Kaba E, Ozkan B, Erus S, Duman S, Cimenoglu B, Toker A. Role of surgery in the treatment of Masaoka stage IVa thymoma. Ann Thorac Cardiovasc Surg. 2018;24:6\u201312.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"1640_CR24","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/1759-7714.12840","volume":"9","author":"J Zhonggao","year":"2018","unstructured":"Zhonggao J, YiJiao W, Yongfeng W, Zhitao P, Jun W, Diansheng L, et al. Multislice computed tomography performance in differential diagnosis of high-density thymic cyst and thymoma in lesions less than 3 cm. Thorac cancer. 2018;9:1300\u20134.","journal-title":"Thorac cancer"},{"key":"1640_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/ejcts\/ezu475","volume":"48","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Chen H, Shi J, Fan L, Hu D, Zhao H. The correlation of morphological features of chest computed tomographic scans with clinical characteristics of thymoma. Eur J cardio-thoracic Surg. 2015;48:698\u2013704.","journal-title":"Eur J cardio-thoracic Surg"},{"key":"1640_CR26","first-page":"1628","volume":"47","author":"YM Sung","year":"2006","unstructured":"Sung YM, Lee KS, Kim B-T, Choi JY, Shim YM, Yi CA. 18F-FDG PET\/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med. 2006;47:1628\u201334.","journal-title":"J Nucl Med"},{"key":"1640_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ejrad.2010.08.010","volume":"81","author":"M Nakajo","year":"2012","unstructured":"Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, et al. 18FDG PET for grading malignancy in thymic epithelial tumors: significant differences in 18FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study. Eur J Radiol. 2012;81:146\u201351.","journal-title":"Eur J Radiol"},{"key":"1640_CR28","doi-asserted-by":"publisher","first-page":"S1509","DOI":"10.21037\/jtd.2017.10.157","volume":"10","author":"S Yokoyama","year":"2018","unstructured":"Yokoyama S, Miyoshi H. Thymic tumors and immune checkpoint inhibitors. J Thorac Dis. 2018;10:S1509\u201315.","journal-title":"J Thorac Dis"},{"key":"1640_CR29","doi-asserted-by":"publisher","first-page":"1722023","DOI":"10.1080\/2162402X.2020.1722023","volume":"9","author":"KH Kim","year":"2020","unstructured":"Kim KH, Hur JY, Cho J, Ku BM, Koh J, Koh JY, et al. Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment. Oncoimmunology. 2020;9:1722023.","journal-title":"Oncoimmunology"},{"key":"1640_CR30","doi-asserted-by":"publisher","first-page":"7635","DOI":"10.21037\/jtd-2019-thym-12","volume":"12","author":"M Jakopovic","year":"2020","unstructured":"Jakopovic M, Bitar L, Seiwerth F, Marusic A, Krpina K, Samarzija M. Immunotherapy for thymoma. J Thorac Dis. 2020;12:7635\u201341.","journal-title":"J Thorac Dis"},{"key":"1640_CR31","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s00259-018-4208-8","volume":"46","author":"R Chen","year":"2019","unstructured":"Chen R, Zhou X, Liu J, Huang G. Relationship between the expression of PD-1\/PD-L1 and (18)F-FDG uptake in bladder cancer. Eur J Nucl Med Mol Imaging. 2019;46:848\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1640_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00259-019-04654-4","volume":"47","author":"L Zhao","year":"2020","unstructured":"Zhao L, Zhuang Y, Fu K, Chen P, Wang Y, Zhuo J, et al. Usefulness of [(18)F]fluorodeoxyglucose PET\/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2020;47:1065\u201374.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1640_CR33","doi-asserted-by":"publisher","first-page":"7553","DOI":"10.21037\/jtd-19-3703","volume":"12","author":"S Yokoyama","year":"2020","unstructured":"Yokoyama S, Miyoshi H. Comparison of PD-L1 immunohistochemical assays and the significance of PD-L1 expression in thymoma. J Thorac Dis. 2020;12:7553\u201360.","journal-title":"J Thorac Dis"},{"key":"1640_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/cancers13040712","volume":"13","author":"J Lee","year":"2021","unstructured":"Lee J, Cho YS, Kim J, Shim YM, Lee K-H, Choi JY. Prognostic significance of metabolic parameters by (18)F-FDG PET\/CT in thymic epithelial tumors. Cancers (Basel). 2021;13:712.","journal-title":"Cancers (Basel)"},{"key":"1640_CR35","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1111\/1759-7714.13464","volume":"11","author":"W Tian","year":"2020","unstructured":"Tian W, Sun Y, Wu Q, Jiao P, Ma C, Yu H, et al. Surgical outcomes of 215 patients with thymic epithelial tumors: a single-center experience. Thorac cancer. 2020;11:1840\u20137.","journal-title":"Thorac cancer"},{"key":"1640_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12149-014-0804-2","volume":"28","author":"N Seki","year":"2014","unstructured":"Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M. 18F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival. Ann Nucl Med. 2014;28:257\u201362.","journal-title":"Ann Nucl Med"},{"key":"1640_CR37","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1158\/1078-0432.CCR-04-1469","volume":"11","author":"Y Ohigashi","year":"2005","unstructured":"Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, et al. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin cancer Res. 2005;11:2947\u201353.","journal-title":"Clin cancer Res"},{"key":"1640_CR38","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1158\/1078-0432.CCR-06-2746","volume":"13","author":"T Nomi","year":"2007","unstructured":"Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H, et al. Clinical significance and therapeutic potential of the programmed death-1 ligand\/programmed death-1 pathway in human pancreatic cancer. Clin cancer Res. 2007;13:2151\u20137.","journal-title":"Clin cancer Res"},{"key":"1640_CR39","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.ejca.2013.02.015","volume":"49","author":"RA Droeser","year":"2013","unstructured":"Droeser RA, Hirt C, Viehl CT, Frey DM, Nebiker C, Huber X, et al. Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. Eur J Cancer. 2013;49:2233\u201342.","journal-title":"Eur J Cancer"},{"key":"1640_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.crad.2015.07.004","volume":"70","author":"H Yabuuchi","year":"2015","unstructured":"Yabuuchi H, Matsuo Y, Abe K, Baba S, Sunami S, Kamitani T, et al. Anterior mediastinal solid tumours in adults: characterisation using dynamic contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET\/CT. Clin Radiol. 2015;70:1289\u201398.","journal-title":"Clin Radiol"},{"key":"1640_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2017.12.016","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Kishida Y, Seki S, Koyama H, Yui M, Aoyagi K, et al. Comparison of interobserver agreement and diagnostic accuracy for IASLC\/ITMIG thymic epithelial tumor staging among co-registered FDG-PET\/MRI, whole-body MRI, integrated FDG-PET\/CT, and conventional imaging examination with and without contrast media Adm. Acad Radiol. 2018. https:\/\/doi.org\/10.1016\/j.acra.2017.12.016.","journal-title":"Acad Radiol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01640-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-021-01640-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01640-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T14:45:59Z","timestamp":1628174759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-021-01640-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1007\/s12149-021-01640-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"22 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}